{"news_desk": "National", "print_page": "20", "section_name": "U.S.", "subsection_name": null, "byline": {"contributor": "", "original": "By SABRINA TAVERNISE", "person": [{"rank": 1, "role": "reported", "firstname": "Sabrina", "organization": "", "lastname": "TAVERNISE"}]}, "abstract": "Food and Drug Administration will strengthen warnings about risk of heart attack and stroke on labels for over-the-counter non-aspirin pain killers.", "type_of_material": "News", "word_count": "435", "lead_paragraph": "Labels on painkillers like ibuprofen that are taken by millions of Americans will be subtly changed to say that they cause an increased risk of heart attack and stroke.", "pub_date": "2015-07-10T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "F.D.A. Is Set to Toughen Nonaspirin Warnings", "print_headline": "F.D.A. Is Set to Toughen Nonaspirin Warnings"}, "snippet": "Labels on painkillers like ibuprofen that are taken by millions of Americans will be subtly changed to say that they cause an increased risk of heart attack and stroke.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/07/10/us/fda-is-set-to-toughen-nonaspirin-warnings.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Pain-Relieving Drugs", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Labeling and Labels (Product)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Ibuprofen (Drug)", "name": "subject"}, {"rank": "6", "is_major": "Y", "value": "Stroke", "name": "subject"}, {"rank": "7", "is_major": "Y", "value": "Heart", "name": "subject"}], "blog": [], "_id": "559f110a38f0d8526a38bb7a", "source": "The New York Times"}